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Case presentation
A 37-year-old white male, who had insulin-dependent diabetes mel-
litus for 27 years, developed seven! complications, including retinop-
athy with blindness, neuropathy, and nephropathy with renal failure.
Proteinuria was present for at least 7 years and ranged between 3 and 5
g/24 hours for the last 4 years. Two years ago, the serum creatinine was
1.2 mg/dl, and one year ago 2.5 mg/dl. During the past year, the serum
creatinine increased to 7.5 mgldl, the creatinine clearance fell from 20
cc/mm to s cc/mm, and the BUN gradually rose from 45 to 130 mg/dl.
Other blood chemistry values included: sodium, 135 mEq/liter; potas-
sium, 3.0 mEq/liter; chloride, 100 mEq/liter; and bicarbonate, 12
mEq/liter. The serum albumin-to-globulin ratio was 3.5/2.5 g/dl.
He had had hypertension for 7 to 10 years, which was poorly
controlled, presumably because of his noncompliance with a therapeu-
tic regimen comprising prazosin and furosemide. Dietary control con-
sisted of avoidance of refined carbohydrate.
The patient began hemodialysis 3 weeks prior to his admission. On
the afternoon of admission to the UCLA Medical Center, and prior to
dialysis, the patient complained of mild nausea and vomiting. His
pre-dialysis weight had increased 2 kg. Blood urea nitrogen was 80
mg/dl; creatinine, 5.4 mg/dl; sodium, 130 mEq/liter; chloride, 98 mEq/
liter; bicarbonate, 18 mEq/liter; and potassium, 4.2 mEq/liter. Calcium
was 9 mg/dl and phosphate 5.6 mg/dl.
Dialysis was begun because of uremic symptoms consisting of
anorexia, weakness, daytime somnolence, and jerking of his hands. The
earliest hemodialysis treatments were tolerated poorly. Near comple-
tion of the first dialysis, a standard 4 hours in duration, he developed
severe headache, agitation, severe nausea, and a marked increase in
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myoclonic jerking movements. The blood pressure rose to 200/110 mm
Hg from a predialysis level of 150/90 mm Hg. He was treated with
diazoxide, and the blood pressure returned to normal. Only after 24
hours did all the symptoms and signs disappear.
At the end of the first dialysis, the blood chemistries were: urea
nitrogen, 60 mg/dl; creatinine, 4 mg/dl; sodium, 129 mEq/liter; potas-
sium, 3.5 mEq/liter; bicarbonate, 27 mEq/liter: and chloride, 100
mEq/liter; the calcium was 11 mg/dl and phosphorus 3.0 mg/dl. Serum
albumin was 4 Wdl. Over the next 3 weeks, the patient was dialyzed 8
times. These treatments were uneventful, and his uremic symptoms and
signs resolved completely during this period, His weight had decreased
3 kg and his blood pressure had returned to normal.
Several weeks later and while on dialysis, the patient again became
confused and hypertensive (blood pressure 190/100 mm Hg). He was
given diazoxide, and his blood pressure returned to its normal range.
The patient became progressively more disoriented, however, and
could not be aroused despite having normal vital signs. His postdialysis
weight could not be determined because of this altered mental status.
By the time he reached the hospital intensive care unit about one hour
later, he was comatose.
Neurologic examination revealed diffuse tremulousness without focal
signs. All deep-tendon reflexes were hyperactive but equal. No patho-
logic reflexes were present. The pupils were normal in size; oculoves-
tibular and oculocephalic reflexes were reactive and normal. He was
unresponsive to all stimuli. A lumbar puncture and CT brain scan were
within normal limits. Electrolyte measurement revealed a sodium of 169
mEq/liter; chloride, 140 mEq/liter; bicarbonate, 20 mEq/liter; and
potnssium, 3.5 mEq/liter. Immediately repeated serum measurements
revealed a sodium of 170 mEq/liter and a calcium of 15 mg/dl. Blood
glucose was elevated simultaneously to approximately 400 nig/dI. A
decision was made to dialyze the patient again, using a calcium-free
bath with sodium and chloride concentrations of 125 and 100 mEq/liter.
After 4 hours of dialysis and free water administration intravenously,
the sodium was 150 mEq/liter and the calcium 11 mg/dl. Over the next
36 hours, the sodium level decreased to 142 mEq/liter. By the end of the
dialysis, the patient was stuporous and arousable, and he responded to
painful stimuli. His mental status progressively improved, A memory
deficit persisted for approximately one week without any additional
neurologic deficit other than his original diabetic peripheral neuropathy.
Shortly after his emergency dialysis, it was learned that an error had
been made in preparing his standard dialysis bath. At the time of this
patient's dialysis, the unit was using a batch-type recirculating delivery
system with the dialysate prepared by the staff, who inadvertently had
added salt paàkets.
Discussion
DR. CHARLES R. KLEEMAN (Scientific Director, Research
Institute, and Director, Division of Nephrology, Cedars-Sinai
Medical Center; and Professor of Nephrology and Medicine,
UCLA School of Medicine, Los Angeles, Cal jfornia): As ne-
phrologists, we frequently are confronted with patients whose
most prominent clinical presentation is an altered state of
consciousness caused by acute or chronic renal failure and/or a
serious disturbance of water, electrolyte, or acid-base regula-
tion. A simple definition of consciousness is awareness of self
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Table 1. Causes of lethargy, stupor, and comaa
Electrolyte
disorder Lethargy Stupor Coma
Hypernatremia + + +
Hyponatremia + + +
Hyperkalemia
Hypokalemia +
Hypercalcemia + + +
Hypocalcemia
Hypermagnesemia
+
+
—
Hypomagnesemia +c
Respiratory acidosis + + +
Metabolic acidosis + + +'I
Respiratory alkalosis + — —
Metabolic alkalosis + + +e
Hypophosphatemia + + +
Hyperglycemia + + +
Hypoglycemia + + +
a From Ref. I; —, no association; +, common association, rare
association.
b Clinical coma secondary to respiratory paralysis, hypoxia, and
hypotension.
Apathy, confusion, inattention.
d Rare with simple acidosis.
Only if severe alkalosis or posthypercapnic alkalosis.
and environment [1]. A diminution of consciousness can be
divided roughly as follows. (1) Obtundation. The patient re-
sponds to verbal stimuli but unusually slowly and often inap-
propriately. This state can be accompanied by disorientation,
fear, delirium, and/or hallucinations. (2) Stupor. The patient is
unresponsive and can be aroused only by vigorous and repeated
stimuli. (3) Coma. The patient is unarousable and nonrespon-
sive, even to repeated noxious stimulation. Each of these states
can be accompanied by almost any focal or generalized neuro-
logic abnormality. Focal or generalized seizures can at times
accompany, or be the cause of, the altered state of conscious-
ness.
Coma results from either a severe dysfunction of the cortex
of both cerebral hemispheres or of the ascending reticular
activating formation of the brain stem and diencephalon, that
part of the brain stem responsible for keeping the cortex
"awake" [2]. Neither diffuse cortical lesions nor lesions of one
cerebral cortex produce coma unless they secondarily affect the
reticular formation in the brain stem. For example, as a
supratentonal mass lesion (such as a tumor, abscess, hemor-
rhage, or subdural hematoma) increases in size, it can compress
and thus distort the brain stem reticular formation. Coma
secondary to a metabolic derangement, however, results from
interference with the metabolism of both brain stem and cere-
bral cortical structures.
In this discussion, I will concentrate on disorders of water
and electrolyte balance, acid-base metabolism, and renal func-
tion which, in their several forms, often cause coma (Table 1).
Note, of course, that the altered states of consciousness that I
described (obtundation, stupor) almost always precede the final
state of coma.
In many cases of stupor or coma, a history is not always
available and the physical examination might not be helpful. A
complete neurologic examination must be carried out, however.
Plum and Posner found that the pattern of change in S physio-
logic variables provides particularly valuable information about
the level of the brain involved, the nature of the involvement,
and the likelihood of progression or resolution of the disease
process [2]. These variables are: (1) state of consciousness; (2)
pattern of breathing; (3) size and reactivity of the pupils; (4) eye
movements and oculovestibular responses; and (5) skeletal-
muscle motor responses. Fortunately, in metabolic disorders,
blood chemistries that indicate the solute and osmolar changes
responsible for the state of the sensorium almost always are
rapidly available. This was certainly the case in the patient we
are discussing today.
What is an appropriate starting point for a discussion of the
brain manifestations of the disordered water and electrolyte
metabolism that this patient displayed? Let me begin with a
brief description of the unique characteristics of the microvas-
culature of the brain, and of the choroid plexus of the lateral and
fourth ventricles. Together these elements form the blood-brain
and blood CSF barriers (BBB/BCSFB), which control the
chemical composition of the brain's extracellular fluid and the
cerebrospinal fluid. These functional and anatomic barriers
determine the microenvironment that bathes all the nerve cells,
their axons and synapses, and the supporting glial or astrocytic
cells of the brain. Thus, the BBB and BCSFB not only are
crucial for normal brain cell function, but they react and
participate in the brain's response to the abnormal blood
composition in disorders of water, electrolyte, and acid-base
metabolism.
The endothelial cells lining the capillaries throughout the
body arise from a common mesenchymal source. Variation
does exist, however, in their ultrastructure and permeability
from organ to organ. The most extreme example of restricted
permeability of these cells, and thus the microvasculature, is in
the brain. The endothelial cells in the brain are connected to
each other by classic tight junctions. These junctions form a
polarized "epithelium" capable of regulating the movement of
small organic molecules and ions between the blood and the
extracellular space of the brain [3—6]. These capillaries in the
brain are almost totally surrounded by astrocytic foot processes
(Fig. 1) [6], which at one time were thought to physically
determine the BBB. These processes cover the greater part of
the capillary surface and share a common basement membrane
with the endothelial cells, but they do not connect with each
other (Fig. 1). Significant gaps between the attachment sites
allow ready passage of proteins and charged or polar molecules
from the interstitial fluid to the antiluminal side of the endothe-
hal cell. The true blood-brain barrier is the unfenestrated
endothelial cells with their complex tight junctions.
The tight intercellular junctions, sparse pinocytotic vesicles,
and absent fenestrae prevent water-soluble and polar sub-
stances from rapidly entering the brain interstitial space and the
synaptic spaces [3, 7]. Figure 2 illustrates the permeability:lipid
solubility relationship of 12 nonelectrolytes in cerebral cortex
[81. The relatively low level of permeability to urea should be
noted. Urea, like sucrose, mannitol, and glycerol, has been
used to shrink the brain acutely in the presence of certain forms
of cerebral edema. I will return to this topic shortly.
Although the astrocytes do not seem to be an anatomic part
of the BBB, they play a fundamental role in its development and
functional characteristics [6, 10, 11]. During fetal development,
the astrocytes (and possibly other brain cells) exert a direct
influence on the differentiation and characteristics of the BBB.
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Table 2. Electrical resistance and potassium or sodium permeability
of endothelial and epithelial tissuesa
Tissue
Resistance
cm2
Permeability
io cm/sec
Frog skin 3600
Brain endothelium 1900 0.03
Toad urinary bladder 1500
Rabbit collecting tubule 860
Necturus gallbladder 300
Necturus proximal tubule 70 0.3
Frog muscle endothelium 20—30 5—15
Rat proximal kidney tubule 5 2.3
Frog mesenteric endothelium 1—3 70
From Ref. 15.
Fig. 1. The close association of endothelial cells in brain capillaries
with foot processes extending from astrocytes. The blood-brain bather
is produced by the continuous endothelium. The astrocytes encircle the
microvessels but are not sealed together, and interstitial fluid has access
(arrows) to the basement membrane and abluminal surface of the
endothelial cell.
The constant close association between astrocytes and endo-
thelial cells in the areas of the brain with a EBB, and the lack of
these contacts in areas without a BEE, provide strong in-vivo
evidence that an interaction between astrocytes and brain
endothelial cells is responsible for the formation of the BBB.
Further, observations suggest that brain tissue contains several
growth factors and that the astrocyte is the most likely cellular
origin of cytokine BBB developmental factors [6, 10, 11].
Finally, Beck and associates demonstrated that a contact or
close association between brain endothelial cells and glial or
astrocytic cells was essential for the presence of the poiar
nature of the sodium-dependent amino-acid transport across the
endothelial cell [12]. All these observations attest to the impor-
tance of the joint interactions between endothelial cells and
astrocytes in the development and function of the BBB.
With respect to ion transport across the BEE, innumerable
experiments over many years indicate that the endothelial cells
of the EBB, relative to the endothelia elsewhere, are compar-
atively impermeable to small ions. In this respect, the EBB
endothelial cells behave much more like classic tight epithelia:
both types display polarity with respect to ion transport from
the luminal (capillary) to the abluminal (basolateral) or brain
ECF side of the cell [7, 11, 12, 131. Given the cellular as well as
paracellular pathways, and hydraulic conductivity of the brain
endothelial cells, water movement across the EBB from the
capillary lumen to brain interstitial space (and vice versa) must
be governed by osmotic forces similar to those in other tight
epithelia. These forces resemble those in the renal tubule rather
than the classic Starling forces across systemic capillaries.
Starling forces cannot be responsible for water transport across
the cerebral capillaries because of the latter's low ion perme-
ability, high reflection coefficient for small ions [14], and high
electrical resistance. Table 2 compares the measurements of the
electrical resistance and sodium or potassium permeability of
brain endothelial cells and various epithelial cells [151. An
interesting clinical observation points out the striking difference
between the capillary bed of the brain and those elsewhere in
the body. Despite the profound, widespread anasarca that can
accompany a severe abnormality in Starling forces across the
capillary (for example, marked hypoalbuminemia), the brain
displays no edema or expansion of its interstitial fluid (1SF)
space. Figure 3, from Crone's careful analysis of the data
supporting the BBB as a tight epithelium, depicts the known
and conjectured pathways existing in the cerebral endothelium
[141.
The composition and volume of the neuronal microenviron-
ment or brain extracellular space is controlled in normal and
disordered states not only by the exchange of solutes and water
across the BBB, but also by exchanges across the plasma
membranes of neurons and glia and across the pia and
ependyma. The latter two structures separate the brain anatom—
ically from the cerebrospinal fluid (CSF) that occupies the
subarachnoid spaces, the ventricles, and the canals. The pia
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Fig. 3. Possible transport systems in cerebral endothelium. On the
luminal side are a coupled Na-H antiport system and a Cl-HC03
exchanger. In the abluminal membrane is a coupled Na-K pump
driven by energy from ATP hydrolysis, pumping potassium ions out of
the cells into the interstitium. This membrane also contains a C1-
HC03 exchanger. The cell chloride (that follows the net sodium
transport) leaves the cell by electrodiffusion. The junction between two
endothelial cells represents the very low conductance passive pathway
that is present in all tight epithelial membranes and presumably also in
the blood-brain barrier. Only two of the many equilibrating transport
systems for organic solutes are indicated, the glucose transporter and
the amino acid transporter (of which there are various types). It is
suggested that the luminal cell membrane has an extremely low perme-
ability to potassium, while the abluminal membrane has a very low
sodium permeability (in accordance with the Kofoed-Johnson-Ussing
double membrane model). (Data from Ref. 14.)
and ependyma present no functional barrier to the virtually free
exchange of water, ions, and nonelectrolytes between the CSF
and the brain ECF. In fact, the vast bulk of evidence indicates
that, in the steady state, the composition of the brain ECF is
almost identical to that of the CSF [16—18]. Cerebrospinal fluid
is secreted by the choroid plexus of the lateral and fourth
ventricles; it flows out by way of the arachnoid villi into the
venous system. Approximately two-thirds of the CSF formed
per unit time results from secretion by the choroid plexus
epithelium. The rest is derived from free diffusion and bulk flow
of water and solutes from the brain ECF. Thus, both the CSF
and the brain ECF can contribute to the composition of the
other, depending on the solute (diffusion) gradients and the
moment-to-moment hydrostatic differences between these two
compartments.
The choroid plexus, the site of the blood-CSF barrier, has
permeability characteristics similar to those of the BBB [7]. In
contrast to the BBB, however, the blood-CSF barrier is located
at the level of the epithelial cells of the choroid plexus rather
than at the capillary endothelium. The capillaries in the subepi-
thelial region resemble those in the systemic circulation in that
they have comparably high permeabilities to solutes and water.
Fig. 4. Working model of ion transport mechanisms across the frog
choroid plexus epithelium. There is net transport of sodium, chloride,
bicarbonate, and fluid toward the CSF, and a small net potassium
transport toward the blood across the choroid plexus epithelium. The
Na-K pump in the brush-border membrane creates steep sodium and
potassium electrochemical potential gradients across the membranes.
The inside negative membrane potential of 45 mV is explained in terms
of K diffusing back into the CSF and the electrogenicity of the Na-K
pump. Under the favorable sodium gradient, sodium enters the epithe-
hal cells across the serosal border via Na-H exchange and sodium
chloride cotransport mechanisms. The latter keeps the intracellular
chloride activity sufficiently high (24 mM) to drive the Cl-HC03
exchange mechanism on the same membrane. Intracellular bicarbonate
is also supplied through carbon dioxide hydration. Carbonic anhydrase
magnifies the rate of uncatalyzed reaction enormously. It is thus
assumed that intracellular activities of both bicarbonate and chloride
are higher than that predicted for passive distribution, and these anions
diffuse into CSF across the brush border down the ehectrochemical
potential gradients. (Data from Ref. 19.)
Thus, the fluid presented to the basolateral membranes of the
overlying epithelial cells represents a typical ultrafiltrate of the
plasma. From this fluid the epithelial cells of the plexus secrete
the newly formed CSF.
Wright and associates, using frog choroid plexus mounted in
Ussing-type chambers, delineated the electrical and ion-trans-
port characteristics of this epithelial membrane [19]. Figure 4
summarizes their findings in a working model [19].
The secretion of CSF by the choroid plexuses is primarily due
to the active transport of sodium by the sodium pumps in the
brush-border membrane of epithelium, and the rate of sodium
secretion is regulated by the bicarbonate permeability. Net
sodium transport is accompanied by net fluxes of bicarbonate
and chloride to maintain electroneutrality, and the transport of
sodium salts is followed by the movement of water along
osmotic gradients. The newly formed choroidal fluid and mixed
(choroidal and brain 1SF) CSF has a low concentration of
protein relative to that in the plasma. Agents that stimulate
production of cAMP greatly increase CSF secretion [19, 201.
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Natural agonists that stimulate CSF secretion include p-adren-
ergic agonists and ACTH [19]. Major inhibitors of secretion
include acetazolamide, ouabain, spironolactone, amiloride, fu-
rosemide, and vasopressin [7, 19].
Given the free exchange of fluid and solutes between the CSF
and the brain ECF, it is clear that the micro-environment of the
neuronal elements must be influenced by the contributions of
both CSF and the fluid formed, that is, "secreted" from blood
to brain ECF across the EBB. In the steady state, the newly
formed CSF contains all the major ions and nonprotein solutes
present in the plasma at concentrations close to those in plasma
water. The choroid plexus epithelium, like the EBB, is able to
regulate the ionic composition of its secretion to prevent major
changes in CSF ion concentrations despite large changes in
their plasma concentrations.
Because water moves into and out of the brain during states
of effective hypo- and hyperosmolality respectively, changes in
the ion and polar solute concentration of the CSF and brain
ECF will occur consistent with the net gain or loss of water
from these fluids. For example, the rise in CSF sodium concen-
tration in response to plasma hypernatremia is the result of
water loss from the CSF rather than any appreciable gain in
CSF sodium [4]. The brain ECF volume is approximately the
same fraction of the total brain fluid volume as ECF throughout
the rest of the body is of total body water, that is, 20%, with the
1SF component being about 15% [7, 18, 21]. Cserr recently
reminded us that in systemic tissues, the net fluid shifts across
the capillary wall and the drainage of 1SF into lymphatics are
important mechanisms for regulation of 1SF volume [221. In
contrast, the cerebral 1SF is separated from blood by the BBB;
there are no lymphatics; and the ependymal and pial surfaces of
the brain are in contact with another extracellular fluid, the
CSF. Cserr and associates and others [22] presented strong
evidence in favor of the model originally proposed by Bradbury
[23]. According to this model, ISP is produced by secretion
across the EBB, whereas volume shifts between brain and CSF
occur via bulk flow. The direction and rate of bulk flow are a
function of the hydrostatic pressure gradient between brain 1SF
and CSF. In the normal steady state, cerebral 1SF volume is
maintained constant despite continual secretion by the EBB
into the CSF. Drainage of 1SF might be sustained by a favorable
hydrostatic pressure gradient (IsF > generated by the
BBB secretion of 1SF. Reversal of this pressure gradient by an
increase in and/or a decrease in P1s will cause a reversal
of flow. Cserr and colleagues demonstrated that; (I) 1SF drains
continuously from the normal brain parenchyma, and the rate of
drainage provides an estimate of the rate of 1SF secretion at the
EBB; (2) elevation of the plasma osmolality from 290 mOsm/kg
H20 to 390 mOsm in the rat by hypertonic saline or mannitol
shrinks the brain, lowers brain 1SF pressure, and reverses 1SF
flow consequent to bulk flow of CSF into the brain. They
observed that the bulk flow of fluid, together with a net uptake
of sodium, potassium, and chloride from 1SF to brain cells,
constitute an effective defense against dehydration of brain 1SF
and brain intracellular fluid. The loss of water at one-half hour
to two hours was only one-third of that predicted if one were to
assume that the brain behaves as a "perfect" osmometer. This
defense of brain volume is in keeping with a regulation of solute
uptake by the brain involving approximately equal amounts of
sodium and chloride, and potassium.
Cserr and colleagues concluded that increased secretion
across the EBB accounted for 20% to 30% of the brain uptake
of sodium and chloride, whereas bulk flow from CSF to 1SF
accounted for approximately 70% to 80% during acute hyper-
tonic stress. Because of the normally low concentrations of
potassium in CSF and plasma, their model accounted for only a
small fraction of the cellular potassium uptake during volume
regulation. Their analysis of the uptake of potassium suggested
that a major component of uptake is mediated by a selective,
osmotically stimulated increase in BBB permeability to potas-
sium.
Conversely, when their animals were made acutely hypoos-
molar by water loading and vasopressin, the swelling of the
animals' brains was only about 50% of what would be predicted
by ideal osmotic behavior. This defense against brain swelling
was primarily due to (1) a bulk flow of excess 1SF from brain to
CSF and then into the systemic circulation through the arach-
noid villi, and (2) a volume-regulatory decrease in brain cell
water due to a loss of sodium, potassium, and chloride; I will
discuss that response later. This work strongly suggests that
any interpretation of the brain's response to hypersmolar and
probably hypoosmolar stress must take into account the inti-
mate interrelationship of 1SF and CSF, transports of ions across
compartments, and the hydrostatic gradients controlling bulk
flow between them.
Our patient today, a 37-year-old man with insulin-dependent
diabetes mellitus for 27 years and end-stage renal disease
treated with chronic hemodialysis, presented us with a number
of acute and chronic metabolic disorders that contributed to, or
were primarily responsible for, his altered states of conscious-
ness. He had longstanding diabetes, and his blood pressure had
been poorly controlled for about a decade; as a result, his
cerebral blood flow and brain microcirculation probably were
affected. For at least one year, he had had severe azotemia.
With his first hemodialysis, he developed a syndrome consis-
tent with dialysis disequilibrium. Three weeks later, during one
of his routine thrice-weekly hemodialyses, over a few hours he
became markedly hyperosmolar and hypercalcemic as the
result of an error in the preparation of his dialysis solutions.
Initially, I will confine my discussion to the causative factors
responsible for the acute brain syndromes in this patient: the
dialysis disequilibrium syndrome, azotemia, acute hypercalce-
mia, and acute hypernatremia. I then will discuss hyponatremia
and water intoxication, hypo- and hyperkalemia, hypo- and
hypermagnesemia, phosphate depletion, and severe hypophos-
phatemia. Although I will treat each as an isolated disorder,
multiple metabolic insults often exist at the same time, as they
did in this patient.
The dialysis disequilibrium syndrome
Because of improved dialysis techniques and our increased
awareness of its probable cause(s), the dialysis disequilibrium
syndrome is seen infrequently today, at least in its severe
forms. The patient presented here, however, was seen a num-
ber of years ago. Central nervous system dysfunction occurred
during his first hemodialysis, which was 4 hours in duration. His
complaints and course were characteristic of those described in
the literature [18, 24—261. The syndrome generally occurs during
rapid or, in the case of initial treatment, during standard 4-hour
dialyses in patients with chronic renal failure; it also occurs in
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Fig. 5. Penetration of urea into muscle,
nervous tissue and cerebrospinal fluid of the
120 150 180 rabbit. Symbols are: (0) muscle; (Lx) grey;(0) brain; (A) white; (•) chord; (+) CSF.
(Data from Ref. 27.)
patients treated with rapid hemodialysis for acute renal failure.
It does not occur with peritoneal dialysis or with pure ultrafil-
tration without dialysis. The exact pathogenesis of the syn-
drome is still in doubt.
It has been known for some time that in the steady state, at
normal or increasingly elevated plasma urea levels, the concen-
trations of urea in plasma and brain cell water are equal [27, 281.
However, urea enters the cells or those areas of the brain
enclosed by the BBB very slowly when compared with tissues
outside the CNS (Fig. 5). It is reasonable to assume that urea
would come out of the brain cells, 1SF, and CSF just as slowly
when the plasma urea dropped rapidly with dialysis [271. Thus,
the hypothesis regarding dialysis disequilibrium supposed that
during dialysis, especially when the BUN was very high to
begin with, or dialysis was very rapid, plasma urea fell abruptly
while the urea concentration within the brain and CSF de-
creased much more slowly. Thus the brain osmotic pressure
would also decrease at a slower rate than that of the blood. This
differential osmolality would cause a shift of water into the
brain and CSF, the brain would swell (become edematous), and
the CSF pressure would rise.
Arieff offered clinical and experimental evidence supporting
this hypothesis [29]. He found that sustaining the effective
osmolality of the blood by the addition of osmotically active
solutes (such as glucose, glycerol, urea, sodium chloride, or
mannitol) to the dialysate prevented many of the clinical and
biochemical manifestations of the dialysis disequilibrium syn-
drome. Despite these findings, early experiments from our
laboratory on acutely uremic dogs undergoing rapid or slow
hemodialysis suggested that the urea gradient between brain
and blood was not great enough to account for the shift of water
into the brain [30, 31]. In addition, during rapid hemodialysis,
we observed a significant decrease in CSF and brain pH while
blood pH was rising. The rise in hydrogen ion concentration in
brain and CSF also was accompanied by an increase in unde-
termined solute concentrations in the brain ("idiogenic" os-
moles). This pH change in the brain was not due to a rise in
pCO2 in arterial blood, because no increase in PaCO2 was
observed. We then speculated that undetermined organic acids
might be responsible for the pH change. Today, however, one
could invoke an inhibition of a sodium-hydrogen antiporter in
the endothelium of the brain and/or the choroid plexus epithe-
hum, or a stimulation of a chloride-bicarbonate exchanger, as
these changes could have the same effect on brain and CSF pH.
We concluded that, at least during rapid hemodialysis in exper-
imental uremic dogs, the brain edema in the dialysis disequilib-
rium syndrome was in some way related to the decrease in brain
pH, and to the generation of "idiogenic" osmoles rather than to
a "reverse" urea gradient. In any event, it has been clear in
clinical and experimental uremia that the dialysis disequilibrium
syndrome can be prevented by sustaining the effective osmo-
lality of the blood during dialysis or, of greater importance, by
dialyzing more slowly and for shorter periods. This latter
approach has all but eliminated the occurrence of this syn-
drome.
"Uremic" encephalopathy
In the patient under discussion, there is no way of knowing
whether diabetes- and/or hypertension-induced small-vessel
disease of the brain contributed to his acute CNS symptoms. It
is clear, however, that he had been chronically uremic until he
began his hemodialysis therapy a few weeks earlier. Table 3,
from Fraser and Arieff, lists the signs and symptoms of uremic
encephalopathy [24]. Most of the findings listed are quite
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Table 3. Signs and symptoms of uremic encephalopathya
Early Moderate Severe
Anorexia Vomiting Itching
Nausea Sluggishness Disorientation
Insomnia Easy fatigue Confusion
Restlessness Drowsiness Bizarre behavior
Decreased Sleep inversion Slurring of speech
attention span Volatile emotions Hypothermia
Inability to Paranoia Myoclonus
manage ideas Decreased cognitive Asterixis
Decreased sexual function Convulsions
interest Inability to decipher
abstractions
Decreased sexual
performance
Stupor
Coma
a From Ref. 24.
common, but frank uremic coma is rare today. Severe impair-
ment of the state of awareness was a manifestation observed in
advanced renal failure in the predialysis era, especially when
there was little control of nitrogen and phosphorus intake. In
fact, the presence of frank coma in an acutely or chronically
uremic patient seen nowadays should make the physician think
of all the structural (for example, tumor, abscess, cerebral
hemorrhage, subdural hematoma) or other metabolic causes
(for example, drug overdose, profound hypo- or hyperglycemia,
severe electrolyte abnormalities) of coma even if the state were
preceded by symptoms listed in Table 3.
Fraser and Arieft', in their recent excellent review of nervous
system complications in uremia [24], have attempted to define a
consistent pattern of biochemical abnormalities in the brains of
animals and humans with acute or chronic uremia. In general,
CNS water, sodium, potassium, chloride, pH, and magnesium
were normal. Cerebral metabolic rate, oxygen consumption,
and consumption of ATP all were below normal. All of these
findings are consistent with a generalized decrease in brain
energy use. However, these metabolic changes do not correlate
with the presence, absence, or degree of neuropsychiatric
abnormalities. In both acute and chronic renal failure in ani-
mals, urea as well as total osmolality are increased, and levels
in blood, brain, and CSF are approximately equal [30, 32]. In
the animals with acute renal failure, the increase in total brain
osmolality is due to urea, but in chronic renal failure in animals
[31, 32] and humans [33], approximately 50% of the increase in
osmolality is due to undetermined solute or "idiogenic" os-
moles.
A consistent biochemical change observed in the brains of
animals and humans with acute or chronic azotemia is a marked
increase in total tissue calcium [34-37]. This finding has evoked
the hypothesis that disordered central nervous system function
in renal failure is related to alterations in parathyroid hormone
metabolism. In dogs, the increase in total tissue calcium can be
prevented by parathyroidectomy despite maintenance of nor-
mal serum calcium, and it can be reproduced by increasing
serum calcium in normal animals given parathyroid hormone.
Remember that PTH receptors have been demonstrated in brain
capillary endothelium [10]. An increase in the serum calcium
and the Ca x P product during vitamin D intoxication does not
increase brain calcium, Dialysis causes a decrease in cerebral
cortex calcium toward normal in patients and animals with
acute or chronic renal failure [35—37]. Thus, excess parathyroid
hormone may be essential for the rise in brain calcium in uremic
animals and humans. Despite this increase in brain calcium, the
CSF calcium concentration remains normal. This observation
suggests that the calcium concentration in brain 1SF also is
normal. Thus, the tissue calcium increase probably is due to an
increase in intracellular calcium and/or plasma membrane cal-
cium.
Some support for this hypothesis comes from work of Fraser
and associates. They recently demonstrated that PTH enhances
calcium transport in uremic rat brain synaptosomes while also
inhibiting the NaK ATPase pump of the synaptosome [38, 39].
The synaptosome represents a peculiar structure found only
after whole-brain homogenization; when brain tissue is homog-
enized, presynaptic nerve terminals can be recovered as de-
tached, sealed structures—synaptosomes. The synaptosomes
contain most nerve terminal cytoplasmic structures and sub-
stances, as well as plasma membrane components. The synap-
tosomes thus resemble miniature non-nucleated cells and have
all the active and passive transport processes of the presynaptic
nerve terminal or dendritic portions of the neuron.
Because calcium transport at the nerve synapses and termi-
nals mediates neurotransmitter release, a defect in the latter
might contribute to the encephalopathy of the uremic animal
and human (Table 3). The rise in calcium due to increased
circulation of biologically active PTH could set in motion a
series of sustained, adverse cellular processes controlled by
either the phospholipase C polyinositol-protein kinase C, or the
adenyl cyclase-cyclic AMP-protein kinase A pathways, both of
which are responsive to PTH.
Because dialysis and parathyroidectomy in uremic animals
and humans causes marked improvement in the abnormal
electroencephalogram and is associated with a decrease in brain
calcium toward normal [401, a significant component of the
encephalopathy of uremia probably is due to secondary hyper-
parathyroidism and its consequences.
Thus in the chronically uremic patient under discussion, who
most assuredly had secondary hyperparathyroidism, we acutely
superimposed a severe, simultaneously hypercalcemic and hy-
pernatremic hyperosmolar state. Either hypercalcemia or hy-
pertonicity by itself could cause a marked disturbance of
consciousness, even in the absence of uremia and hyperpara-
thyroidism [1, 2, 18, 41].
Hypercalcemic encephalopathy
When the normal brain is exposed to severe hypo- or hyper-
calcemia, whether acutely or chronically, the calcium concen-
tration in the CSF and brain remains remarkably close to
normal (Fig. 6); the blood-brain barrier and blood-CSF barrier
present formidable obstacles to a significant deviation [7, 18, 23,
42]. Merritt and Bauer reported in 1931 that the CSF calcium
(mean concentration 4.5—5.5 mg/dl) did not change significantly
over a range of serum calcium from 4.45 mg/dl to 14.0 mg/dl in
patients and animals with clinical and experimental hypo- or
hyperparathyroidism [42]. This work has been confirmed
(through similar ranges of serum calcium of various causes) on
a number of occasions since then [18, 36, 37]. Given that the
calcium concentrations in CSF and brain 1SF probably are
equal, the fact that the CSF electrical potential is about S mV
positive with respect to the plasma [43] suggests that there is a
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regulated active transport mechanism across the BBB and
BCSFB that is independent of the action of PTH. This obser-
vation is of particular interest because, as I said, PTH is
responsible for the increased amount of calcium in the brain of
uremic animals.
Merritt and Bauer also found that the baseline inorganic
phosphate concentration in the CSF of hypoparathyroid pa-
tients was about one-third the concentration in the simulta-
neously collected plasma [421. Exogenous PTH, which elevated
the total plasma calcium from a mean of 10.0 mgldl to 11.8 mg/dl
in 7 subjects, had no effect on CSF inorganic phosphate, and the
CSF/plasma concentration ratio remained about one-third. If
we assume that the protein binding of inorganic phosphate in
the serum is approximately 25% and that the electrical potential
in CSF is about S mV higher than that of the plasma, we can
conclude that the BBB and BCSFB, together with brain cell
transport of inorganic phosphate, keep the CSF phosphate at a
low concentration; this conclusion is consistent with one or
more active extrusion mechanisms.
Very little data are available with respect to the homeostatic
mechanism controlling the transport of calcium into and out of
the brain. Given that brain 1SF calcium concentration is in the
lO M range, that is, the same range of systemic 1SF, it seems
reasonable to assume that the normal cytosolic calcium ion
concentration in neurons and glial cells is in the same range as
non-CSF tissues, that is, iO M. Further, comparable mem-
brane transport mechanisms probably sustain this gradient in
and outside of the CNS [38, 39]. Tower reported from in-vitro
studies of cat cerebral cortex that the addition of ouabain (10—s
M) caused a two- to threefold increase in tissue and mitochon-
drial calcium [44]. This finding suggests that the ouabain-
sensitive transport process, that is, the sodium-potassium ATP-
ase pump, is critical in maintaining tissue calcium in the brain
just as in other (non-CNS) tissues. How a moderate to severe
increase in the calcium concentration in the plasma, especially
when it occurs over a brief period, can cause coma as well as
other serious neurologic signs and symptoms is currently un-
Fig. 6. Each point on the graph represents
the simultaneous determination of calcium
both in serum and in cerebrospinal fluid. In
these experiments, although the serum
calcium varied from 4.5 mg/tOO cc to 13.9 mg/
100 cc, the cerebrospinal fluid calcium
remained within the range of 4.45 mg/I00 cc
to 5.6 mg/lOO cc. (From Ref. 42.)
known. It is paradoxical that hypercalcemia can seriously
disturb the brain, even though the normal BBB and BCSFB can
protect the intra- and extracellular fluids of the brain against
large deviations in plasma calcium [7, 18, 23, 42, 45]. To my
knowledge, no careful clinical investigations are available to
determine whether severe hypercalcemia in the presence of
high PTH causes more serious or prolonged CNS signs and
symptoms than does the same degree of hypercalcemia of
similar duration in matched patients in the absence of high
PTH. Dubois and Arieff, in their comprehensive review of the
clinical manifestations of electrolyte disorders, do not address
this point [1].
We might expect that our patient's mental status would be
highly susceptible to acute severe hypercalcemia. Indeed, he
quickly lapsed into deep coma within one hour of completion of
his dialysis, at which time his serum calcium was 15 mg/dl.
Undoubtedly this rapid alteration was in part related to the
acute hypernatremia that was present simultaneously. Although
long-term dialysis probably is associated with a return of brain
calcium to normal, this patient had been undergoing dialysis for
only 3 weeks. In patients predisposed to abrupt marked rises in
serum calcium, such as those with acute or chronic renal failure
with a complicating hypercalcemic disorder, the kidney loses its
ability to excrete the calcium, and this change can prompt a
course similar to the one observed in this patient. Table 1 lists
the electrolyte disorders most associated with stupor and coma.
The reader is referred to the review by DuBois and Arieff for a
description of the CNS manifestations of hypercalcemia.
It has been my experience that, with an occasional notable
exception, the older the patient, or the younger the patient in
the pediatric age group, the more prominent are the CNS
manifestations of acute or chronic hypercalcemia. The reason
for the apparent vulnerability of the brains of patients in these
age groups is unclear. The elderly and the very young also seem
to display the greatest disturbance of consciousness and asso-
ciated neurologic manifestations in response to other electro-
lyte disorders, such as hyper- and hypoosmolar states. Snyder
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and associates have stressed that the vast majority of hyperna-
tremic patients have other serious medical or surgical disorders
that could predispose them to both the hyperosmolar state and
to the brain dysfunction [46].
Hyperosmolar states
Hypernatremia results from water loss in excess of isotonic
proportions of sodium chloride or sodium bicarbonate, or from
an increase of one of these salts without a proportionate gain in
the amount of water. Thus total-body water can be normal,
reduced, or elevated, but in all cases water is lost (to varying
degrees) from every cell in the body. Cellular dehydration, of
course, is secondary to the movement of water along its
osmotic gradient because the permeability of body cells to
sodium from the basolateral or circulatory side of the cell is
quite low. When the rise in extracellular osmolality is acute, the
fractional loss of water from cells examined is quite uniform.
Later, however, various cells or organs deviate from the water
loss predicted by the assumption that the cells or organs behave
as perfect osmometers.
In our laboratory, we infused hypertonic glucose rapidly into
rabbits so as to elevate their plasma glucose to 60 mM (1100
mg/dl) in one hour [47]. This level was then maintained for 4 to
6 hours. At 2 hours the fractional losses of water from brain and
skeletal muscle were equal: slightly more than 10%. By 4 hours,
however, the brain water content had returned to normal, but
that of the muscle remained depressed. This remarkable recov-
ery of the water content of the brain to normal despite sustained
and marked hyperosmolality of the plasma is an example of
complete "volume regulatory increase." Such regulation of cell
volume is observed to varying degrees in many areas of the
body, but nowhere is it more complete than in the brain. In our
experiments, the skeletal muscle cells at 4 hours showed no
volume regulatory increase. In contrast to systemic tissues, the
unique characteristics of the BBB and BCSFB that I described
earlier allow for maximal maintenance of brain volume despite
the hyperosmolality of the blood. Recall that the "tight"
epithelium-like properties of the capillary endothelium of the
brain, together with the intimate relationship on both a hydro-
static and compositional basis between the brain 1SF and the
CSF [22], allow for both the intracellular and the 1SF volume to
minimize deviations from normal. The brain cells regain normal
water content with an increased solute content after the acute
hyperosmolar stress has caused the loss of 1SF and cellular
water, despite the sustained ECF hypernatremia or hyperosmo-
lality.
All animal studies of acute hypernatremic states have dem-
onstrated varying degrees of volume regulatory increase in the
brain. The more acute and severe the hypernatremic or hyper-
osmolar state (induced by hypertonic saline, urea, or glucose),
the more severe is the initial dehydration and contraction of the
brain, and the more severe the neurologic syndrome. If the
initial hypernatremia and hyperosmolality are less severe, the
majority of animals survive despite a sustained hyperosmolar
state for many hours or days. After this period, volume regu-
latory increase is maximal. The cells have gained sodium,
chloride, and potassium as well as nonelectrolyte solutes (in-
cluding in part certain amino acids), and brain volume has
returned to normal [18, 29, 41, 48—52).
Studies of "volume regulatory increase" and "volume regu-
latory decrease" in other cells and tissues suggest that dehy-
dration of the cells in response to hyperosmolar stress leads to
activation of the coupled Na/K/2Cr co-transport system
and/or the chloride/bicarbonate exchanger and the sodium!
hydrogen antiporter in the plasma membrane [52]. The parallel
activation leads to a gain in cellular sodium and chloride in
exchange for hydrogen and bicarbonate respectively, and a
probable decrease in potassium conductance out of the cell.
The net effect is a cellular gain in sodium, potassium, and
chloride, a rise in intracellular osmolality, and a return of cell
volume toward normal. It is probable that these cellular mech-
anisms are responsible for part of the "volume regulatory
increase" occurring in brain cells. However, in numerous
experiments carried out by Arieff and associates during the past
15 years [29—31, 47, 48], the gain in osmolality in brain cells
after administration of hypertonic sodium chloride and hyper-
tonic glucose could not be explained by the osmotic equivalent
of the gained electrolytes. We used the term "idiogenic os-
moles" to define the undetermined solutes [47], a term first used
by McDowell and associates [53] with respect to systemic
tissues and by Sotos and colleagues with respect to brain [52].
The relative contribution of electrolyte uptake or nonelectro-
lyte "idiogenic" osmole accumulation to the total increment in
cell osmolality differs depending on the nature of the solute
causing the hyperosmolar state [51]. Culpepper et al suggested
that the acute achievement of osmotic equilibrium is almost
solely due to cellular water loss [51]. Subsequently, electrolyte
gain and idiogenic osmole accumulation account for the solute
gain and return of brain water to normal. About 50% to 60% of
the osmoles responsible for volume regulation during chronic
hypernatremia are amino acids [48, 49], and the remainder are
the result of sodium, chloride, and potassium uptake. During
hyperglycemia, about 50% of the volume regulatory increase
consists of electrolytes and a small amount of glucose, and 50%
are idiogenic osmoles [47, 48]. The exact nature of these
osmoles has not been determined. We do know, however, that
they are not amino acids. The increment of idiogenic osmoles
seems to be the consequence of hyperglycemia and not hyper-
osmolality, because a comparable increase in osmolality with
glycerol, sucrose, or mannitol does not generate idiogenic
osmoles and does not cause a volume regulatory increase. As
Culpepper and associates noted, the lack of volume regulation
with these particular exogenous solutes (glycerol, sucrose, and
mannitol) accounts for their usefulness in reducing brain vol-
ume in patients with cerebral edema [51].
Another important point stressed by Culpepper from the data
of Arieff [29] and others [54] is that, in contrast to the amino
acids that accumulate during hypernatremic states, the "idio-
genic" osmoles of hyperglycemia disappear rapidly as the
plasma glucose falls [47, 48, 55]. Thus, rapid reduction in
plasma glucose in hyperglycemic hyperosmolar coma leads to
rapid and progressive improvement in the comatose state,
whereas comparably rapid reduction in serum osmolality to
normal in hypernatremic states can precipitate convulsions.
I mentioned earlier that if the initial acute hypernatremic
insult is severe, the animal or patient can die during this phase
without evidence of volume regulation. A partial explanation
for this observation may be derived from the work of Rapoport
and Robinson, who demonstrated that the tight junctions of the
endothelial cells that restrict intercellular diffusion of ions,
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Fig. 7. Model for osmotic BBB opening at
cerebral capillary. Hypertonic perfusate
removes water from endothelial cells and from
brain parenchyma, and thereby produces
vasodilation and endothelial cell dehydration.
The net effect is stretching of the endothelial
cell membranes and an increase in
permeability of intercellular tight junctions.
(Data from Ref. 56.)
proteins, and water-soluble nonelectrolytes, can be opened by
osmotically induced shrinkage of the endothelial cells of the
BBB [561 (Fig. 7). The more water soluble the solute and the
higher its reflection coefficient, the more it is able to "open" the
BBB when in contact with the endothelium in hypertonic
concentrations; for example, I molar. This "opening" of the
BBB would leave the brain tissue unprotected.
Let's return to today's patient again. His hypernatremic state
was due to an acute load of hypertonic salt solution without
water depletion. The rise of serum sodium of more than 30
mEq/liter in 4 hours was a major factor in the pathogenesis of
his metabolic coma. Therapy lowered his serum sodium to 150
mEq/liter within 4 hours, and over the next 36 hours his serum
sodium decreased to 142 mEq/liter. This rate of chemical
recovery was paralleled by his clinical recovery, without any
adverse CNS reactions and with no evidence of persistent brain
damage.
Pathologic studies of the brain in humans and animals follow-
ing severe acute hypersomolar salt loads demonstrate normal or
shrunken brains, severely engorged vessels, capillary rupture
with petechial hemorrhages, and larger parenchymal and sub-
arachnoid bleeding. These disorders usually have been associ-
ated with plasma osmolalities of 350 to 450 mOsm/liter [57, 581.
The mortality rate in patients with hyperosmolality of this
severity can exceed 50% [29]. In humans and animals, the more
chronic the development of hypernatremia and the less extreme
the hypertonicity (serum sodium less than 160 mEq/liter), the
less symptomatic the patient or animal and the lower the
mortality rate.
When one treats hypernatremia in humans, the rate of the
return of serum sodium to normal should be a function of the
severity and the rapidity of its development. This patient
developed hypernatremia over 4 hours. It is probable that little
volume regulation took place over this time. Thus, the serum
sodium probably could have been returned to normal over, at
most, a 12- to 24-hour period without fear of an adverse CNS
reaction. On the other hand, if the duration of the hyperna-
tremic state is unknown, especially when serum sodium is
above 160 mEq/liter, correction should be extended over 2 to 4
days. Arieff [29] and Snyder and coworkers [46], after an
extensive review of the available literature on this point,
suggested that correction take place over at least 48 hours, or at
a rate of decrease of serum osmolality of 2 mOsm/kglhour.
However, they did not distinguish between acute and chronic
development of the hypernatremia.
The longer the duration of the hypernatremic state, the more
likely that volume regulation will be complete; that is, the brain
cell content of solutes is increased and brain volume is normal.
Too-rapid correction of the hypernatremia by free water admin-
istration at this time will result in overexpansion of the cellular
volume and may cause cerebral edema. Time must be given to
permit the volume regulatory effects on the brain to dissipate.
Slow correction should be the password. I recommend a rate of
reduction of serum osmolality and serum sodium of about 1
mOsm/kg and 0.5 mEq/liter per hour, respectively.
The urgency of our treatment often is dictated by the severity
of the CNS symptoms of the patient. Although any combination
of neuropsychiatric signs and symptoms can exist in the hyper-
osmolar syndromes, the common denominator seems to be the
degree of hyperosmolality. When other variables are controlled
[1, 29, 481, the alteration of the state of consciousness (as
defined by Plum and Posner [12]) can best be correlated with the
absolute rise in serum osmolality [48] (Fig. 8). Frank coma
rarely occurs in animals or humans below an effective serum
osmolality of 340 mOsm/liter. "Effective" means that the rise in
serum osmolality is due to a solute that does not readily cross
the BBB or that has a high reflection coefficient. But the fact
that many patients and animals may have only grade- 1 or
grade-2 depression of consciousness (on a scale in which coma
is given a grade of 4 and 5) with osmolalities of 340—360
mOsm/liter suggests that, in these cases, a more complete
degree of volume regulation has occurred. To my knowledge,
no study has been done to relate the degree of volume regula-
tion (the degree of return of brain water to normal) to the level
of consciousness in an individual animal at plasma osmolalities
above 340 mOsm/liter.
Hyponatremia and hypoosmolality
For the purpose of our discussion, I will consider only those
states in which hyponatremia and hypoosmolality are synony-
mous. This state is the most common disorder of water and
electrolyte metabolism. In it severe form, it also is the most
frequent cause of metabolic coma with or without seizures or
other neurologic manifestations. In chronic hyponatremia, the
patient or animal can be remarkably free of CNS manifesta-
tions, with serum sodium concentrations between 110—115
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FIg. 8. The state of consciousness is shown in relation to the peak
serum sodium (Na) level at the time of diagnosis. There was a definite
trend toward increased depression of consciousness with increasing
serum sodium values, although there was substantial overlap among
categories. Criteria for depression of sensorium are based on definitions
by Plum and Posner [2]. (Data from Ref. 48.)
mEqlliter. This observation is a sign of volume regulation in
response to brain cell overhydration and 1SF volume expan-
sion. The causes of hyponatremia are well known. In all cases,
the hypoosmolar state results from either an absolute or relative
excess of water in the body. It can occur with or without
edema, and with or without salt depletion or reduced ECF
volume. In all cases, water intake is excessive relative to the
kidney's ability to excrete it. The morbidity, clinical presenta-
tion, and mortality rate of patients with hyponatremia are
related to the age of the patient (the oldest and youngest are
most affected), the acuteness of the decline in serum sodium,
the severity of the hyponatremia, and the concomitant presence
of certain medical conditions.
Probably the first comprehensive study of pure water intox-
ication in humans and animals (dogs) was published by Weir
and associates in 1922 [59]. Some of their patients with diabetes
insipidus who received posterior pituitary extract for the first
time continued drinking fluids despite the antidiuretic effect of
the extract. The result was acute water intoxication. The
authors reproduced this state in dogs, and the resulting syn-
drome was remarkably similar to that which we observe today
in the patient or animal with an acute hypoosmolar state
secondary to water excess [1, 29]. Typical manifestations are
nausea, vomiting, asthenia, ataxia, convulsions followed by
coma, and finally, complete recovery. In 1931, McQuarrie and
Peller reported the deliberate induction of hyponatremia in
children as a diagnostic test for epilepsy [60].
Neurologic manifestations of acute water intoxication (<24
hours) in humans and animals usually do not appear until serum
sodium has fallen below 125 mEq/liter [61]. When the hypona-
tremic state develops more slowly, however (that is, over a
number of days or longer), the animals can be asymptomatic
even with serum sodium concentrations as low as 100 mEq/liter
[61]. At these levels most humans manifest some alteration in
FIg. 9. Brain content of Na, K, C1, and water in normal animals
and in rabbits with hyponatremia of 16 days duration (plasma Nat 99
mEqiliter). In the hyponatremic animals, brain water content is 7%
above normal, and brain content of Nat !C', and CL is 17% to 37%
below normal. The loss of electrolytes by brain prevented a more
substantial gain in brain water. Shaded bars represent hyponatremic
animals, and brackets are mean + SE. (Data from Ref. 61.)
consciousness and occasionally convulsions. Brains from pa-
tients or animals with acute water intoxication and marked
hyponatremia have generalized swelling and a definite increase
in water (brain edema). The increment in brain water, however,
usually is proportionately less in the brain than in other tissues
such as muscle and liver [50, 62, 631.
In 1935 and 1940, Darrow and Yannet [64] and Yannet alone
[65] reported their studies of water excess, with and without salt
(sodium chloride) depletion, in a variety of animals. Their
results with respect to the brain were about the same with or
without salt depletion, but the hyponatremia associated with
salt depletion was somewhat worse with respect to symptoms.
After 24 hours of severe hypoosmolality, muscle and liver water
was greatly increased, but brain water had returned almost to
normal in association with a significant decrease in sodium,
potassium, and chloride content. They concluded that this loss
of solute was an adaptation that allowed the brain to correct the
initial water excess. Theirs was the first demonstration in vivo
of volume regulation in states of hypotonicity. Subsequently,
many studies of brain solute and water composition in response
to acute and chronic water overload with hyponatremia have
demonstrated that the brain's (1SF, CSF, and cells) response to
acute hyponatremia (over the first 1—2 hours) is to attain
osmotic equilibrium with the plasma. Thus, acutely the cells
gain water and swell, and intracellular solutes are diluted.
Subsequently, the process of volume regulation is set in motion,
yielding a progressive loss of cellular sodium, potassium, and
chloride. These electrolytes can reach their lowest level (ap-
proximately 80% of normal in rat studies) in 7 hours [62, 63, 66].
This movement of electrolytes is followed by a somewhat
slower loss of organic solutes, primarily certain amino acids,
over a 24- to 72-hour period [67, 68]. Those processes are
accompanied by a return of cell and 1SF volume to or toward
normal. Therefore, in the more chronic hyponatremic states
(days instead of hours), for any given degree of hyponatremia,
there is little or no increment of brain water (Fig. 9). These
physiologic adjustments account for the much lower morbidity
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and mortality rates of animals and humans with chronic hypoos-
molar states. These alterations also provide an explanation for
so-called "asymptomatic hyponatremia."
The cellular transport processes responsible for volume reg-
ulation during hypotonicity in the brain are unknown. Volume
regulation has been demonstrated in many cell types in re-
sponse to hypotonicity of the ECF, however, and the ion loss is
similar to that of the brain. Such losses could include a marked
increase in potassium conductance and/or K—/Cl— cotransport,
or an inhibition of the Na/K/2Cl cotransporter in response to
volume expansion. I will discuss the implications of volume
regulation on the therapeutic correction of the hyponatremia in
a moment.
Arieff, who has extensive experience with the most serious
examples of hypo- and hyperosmolar syndromes, has con-
cluded that in the most severe and acute of the syndromes, the
mortality rate is extremely high, as much as 50% to 70% [29].
Recently he reported 15 patients he had seen over a 10-year
period [69]. These were healthy women (age range, 22—66 years;
mean, 44 years) having elective surgery at various hospitals.
Each developed profound hyponatremia (mean 108 mEq/liter)
secondary to massively excessive hypotonic fluid administered
in the postoperative period in conjunction with a failure to
excrete the water (mean + balance, 7.5 liters). The failure of the
kidneys to excrete water most likely was due to sustained
release of antidiuretic hormone, a common phenomenon in the
operative and immediate postoperative period. Typically, at 2
days post surgery, generalized grand mal seizures developed in
the patients; 60 minutes later, respiratory arrest required intu-
bation. The patients developed a wide variety of neurologic
syndromes. On average, 16 hours elapsed before therapy for the
hyponatremia was started; overall, the rate of rise of serum
sodium to a serum sodium of 128 mEq/liter with hypertonic
saline was at the relatively slow rate of 0.5 mEq/liter/hour.
Figure 10 displays the course and outcome of one-half of these
patients: 27% died, 13% had limb paralysis, and 60% were left
in a persistent vegetative state. No specific brain histology was
found in 5 patients (3 autopsies; 2 open-brain biopsies), and no
Fig. 10. The clinical course in 7 women who
had postoperative hyponatremia with grand
ma! seizures and coma. When the serum
sodium level was increased from 105 to 131
mmol/liter in 41 hours, all the patients awoke.
However, after a mean period of 58 hours,
grand mal seizures and recurrent coma
developed in all 7 patients even though the
serum sodium level exceeded 128 mmol/liter
1 2 9 in all cases. One patient died, and the others- years have remained in a vegetative state. (Bars
denote SE. (From Ref. 69.)
evidence of central pontine myelinolysis was found. Arieff
noted that all these patients were women. He reviewed reported
cases with comparable profound hyponatremia and found that
85% of the patients were women; moreover, all 30 of the
patients who either died or had permanent brain damage also
were women. His conclusion, that this syndrome of brain
damage and death from severe hyponatremia is primarily a
female disorder, deserves careful study in a larger group of
patients.
Chung and associates carried out a prospective study at the
University of Colorado Health Sciences Center on adult pa-
tients whose serum sodium fell below 130 mEq/liter within one
week of surgery [701. They found that 48 of the 1088 patients fell
into this category and that these patients had a mean serum
sodium of 126 mEq/liter. The patients had a wide variety of
disorders, many being far sicker initially than the healthy
women in Arieff's study [69]. Hyponatremia was not associated
with significant neurologic deterioration in these postoperative
patients. All developed hyponatremia from the postoperative
administration of hypotonic fluids. Despite the low serum
sodium concentration, all the patients studied had detectable
levels of plasma arginine vasopressin. From the standpoint of
hypoosmolality, these cases are less severe than those reported
by Arieff [691. Despite the benignity of hyponatremia in
Chung's series, severe hyponatremia (serum sodium less than
120 mEq/liter) and acute hyponatremia (fall in serum sodium
over a period less than 24 hours or, at most, 48 hours) is a
serious disorder that can cause permanent or fatal brain damage
[29]. This combination of problems demands prompt correction
toward a higher but slightly subnormal serum sodium with
hypertonic sodium chloride. The studies by Sterns and associ-
ates of rats with convulsions and coma induced by severe acute
hyponatremia (fall in serum sodium to 106 mEq/liter over 7
hours) are of some interest [661. Animals that had been this
hyponatremic for 24 hours or less did well regardless of how
rapidly their electrolyte disturbance was corrected.
The problem confronting the clinician is when and how to
treat patients whose serum sodium level is below 120 mEq/liter.
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This fascinating and controversial subject is beyond the scope
of the present discussion but will, I understand, be the focus of
a Forum in the near future.
Other electrolyte disturbances
Hypo- and hyperkalemia. While peripheral neurologic mani-
festations of varying severity occur in patients with severe
hypokalemia (serum potassium less than 3.0 mEq/liter) or
hyperkalemia (serum potassium greater than 6.5 mEq/liter),
obtundation, stupor, or coma are practically never seen [1].
This appears to be the case in both acute and chronic deviations
of serum potassium from normal. In fact, the presence of a
significant alteration in consciousness in such a patient should
initiate a search for another cause. These clinical observations
might well be expected from the experimental studies that have
demonstrated the remarkable stability of the potassium concen-
tration of brain, CSF, and newly formed ventricular fluid in the
presence of marked acute and chronic changes in plasma
potassium [4, 18]. This stability is the consequence of the
barrier mechanisms and influx and efflux transport characteris-
tics of the choroid plexus epithelium and the endothelial cells of
the brain capillaries [4, 14, 15, 19].
Hypophosphatemia. In 1977, Knochel reviewed the patho-
physiology and clinical characteristics of acute and chronic
phosphate depletion [71]. He stated, The effects of hypophos-
phatemia on the CNS have been tentatively characterized in
terms of symptoms but unproven in terms of pathophysiology."
That statement is valid today. Nevertheless, confusion, obtun-
dation, convulsions, and coma can be caused by marked
hypophosphatemia (less than 1.5 mg/dl) secondary to phosphate
depletion. These symptoms most often are seen in cachectic
malnourished alcoholics and/or severely debilitated patients
who have received parenteral or oral nutrition with inadequate
supplies of phosphorus. In the animal models of severe phos-
phate depletion, even when serum phosphate is below 0.8
mg/dl, CNS manifestations can be minimal unless the animal is
starved and then subsequently infused with glucose/amino acid
solutions that cause a fall in serum phosphate below 0.2 mg/dl in
less than 2 days [72]. It has been demonstrated repeatedly in
humans and animals that severe phosphate depletion is associ-
ated with intracellular deficits of inorganic phosphate ATP and
other high-energy phosphates in red cells, muscle, white cells,
and platelets. The deficiency of 2,3 diphosphoglycerate in the
red cell is associated with an impaired release of oxygen from
oxyhemoglobulin in the tissues and possibly can result in tissue
hypoxia [29, 72]. Although these metabolic derangements can
be present in the brain, to my knowledge they have not been
studied. The organic and inorganic phosphate metabolism of the
brain and the transport characteristics for phosphate of the
BBB and BCSFB in phosphate depletion remain a fertile field
for investigation.
Hypo- and hypermagnesemia. Neither of these abnormali-
ties, whether occurring acutely or chronically, has been clearly
shown to cause coma [1, 29, 73]. Hypomagnesemia and mag-
nesium depletion, however, are associated with irritability of
the nervous system. The coma occurring during profound
hypermagnesemia (serum magnesium, 12—15 mEq/liter) in ani-
mals is always preceded by profound hypoventilation, hypoten-
sion, and hypoxemia [73]. Thse disorders presumably are the
primary causes of the comatose state. As noted with potassium,
acute and chronic experimental hypo- and hypermagnesemia
are associated with little or no changes in brain or CSF
magnesium [18, 29, 74]. The same regulatory ability of the BBB
and the BCSFB appears to exist for magnesium.
Questions and answers
DR. MARSHALL FICHMAN (Clinical Chief, Nephrology, Ce-
dars-Sinai Medical Center, Los Angeles, California): In the
adaptation of brain volume to chronic hyponatremia, if the
brain water returns to normal, how does fluid restriction with
correction of the hyponatremia improve the patient's clinical
status?
DR. KLEEMAN: It seems reasonably clear from the observa-
tions in hypotonic humans and animals that when the level of
brain water has returned to normal, the subject is only mildly,
if at all, symptomatic. Now when we make the decision to
correct the hyponatremia by water restriction, and the serum
sodium slowly returns toward normal, we can expect to see the
slow, complete reversal of the volume regulatory phenomena;
that is, the sodium, potassium, chloride, and other solutes will
return to normal levels in the brain, and total brain water will
remain normal. At this point, we would expect the subject to
have lost all CNS symptoms and signs caused by the hypoos-
molar state.
DR. ATUL T. RoY (Renal Fellow, Sepulveda Veterans Ad-
ministration Medical Center, Sepalveda): Why is there a need
for idiogenic osmole formation in the brain in experimental
chronic renal failure if, as you noted, urea attains equilibrium at
equal concentrations in plasma and brain water?
DR. KLEEMAN: That's a good question. I have no explana-
tion.
MR. MARVIN LEE (Student, UCLA School of Medicine): If
the brain generates idiogenic osmoles in response to hyperos-
molar states, why does the brain generate idiogenic osmoles
when serum osmolality is decreasing in dialysis disequilibrium?
This response is nonphysiologic and can cause the brain to
swell.
DR. KLEEMAN: Our experiments with rapid and slow dialysis
in experimental renal failure in dogs [27] gave us the impression
that the solutes responsible for the intracellular acidosis accom-
panying rapid dialysis could be responsible for the rise in
idiogenic osmoles. We did not get closer to a specific explana-
tion.
DR. JACK COBURN (Nephrology Division, Cedars-Sinai Med-
ical Center and Wadsworth VA Medical Center): It is my
clinical impression that patients with end-stage renal disease are
much more susceptible to symptomatic alterations of CNS
function or depressed consciousness during hypercalemia than
are hypercalcemic patients with normal renal function. Do you
agree about the increased susceptibility of uremic patients to
hypercalcemia, and would you comment on the possible mech-
anisms?
Before you answer, let me make another point. For complete-
ness in the discussion of altered consciousness and abnormal
mental function in patients with renal failure, one must include
acute aluminum toxicity. This has been seen most commonly in
patients undergoing dialysis with aluminum-contaminated wa-
ter, but the syndrome can develop under certain other circum-
stances. Patients with advanced renal failure not yet requiring
dialysis who are treated with both aluminum hydroxide and
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Shohi's solution (sodium citrate/citric acid) for one to two
months have developed convulsions, altered mental function,
coma, and even death with markedly elevated plasma aluminum
levels. This occurs because citrate markedly increases alumi-
num absorption and also can aggravate the CNS manifestations
of aluminum toxicity. Also, the CNS symptoms of aluminum
toxicity often are remarkably worse during the last hour of a
dialysis session or immediately after.
DR. KLEEMAN: I agree with your clinical observations.
However, I know of no study in nonazotemic patients compar-
ing patients with central nervous system manifestations associ-
ated with hypercalcemia secondary to parathyroid hormone
excess with matched patients with hypercalcemia of the same
degree without parathyroid excess. Thus I'm not sure that
there's definitely a difference, even though in the azotemic
patient or animal, the removal of parathyroid hormone results
in an improvement in brain function.
DR. JOEL KOPPLE (Chief, Nephrology Division, Harbor-
UCLA Medical Center): In severe hypernatremia of sudden
onset, how rapidly do the idiogenic osmoles increase?
DR. KLEEMAN: They can be found at increased levels within
3 to 4 hours after the onset of hypernatremia. I do not know of
any studies to determine the minimum time necessary for their
appearance.
DR. IaA KURTZ (Associate Chief, Nephrology Division,
UCLA School of Medicine): In the data from Culpepper, it
appeared that following acute urea loading—as opposed to
sodium or glucose loading—the brain water content decreases
acutely and then increases in the absence of a change in brain
electrolyte content and with only a small change in idiogenic
osmole content. What is the mechanism of the increase in brain
water content?
DR. KLEEMAN: In our early rabbit experiments with urea
infusion (Fi'. 5), we continued to monitor the animals for 12 to
24 hours. We noted that between these times, all areas of the
brain attained the same level of urea as observed in plasma
water, that is, 300 to 400 mgldl. Without a measurement of brain
osmolality at that time, we couldn't detect idiogenic osmoles.
Also, we did not measure brain electrolyes in these experi-
ments. The brain water between 12 and 24 hours was normal
when urea reached equilibrium with the blood. It would be
appropriate at that time for the brain water to return to normal.
DR. MARTIN ROBERTS (Dialysis Consultant, Sepulveda Vet-
erans Administration Medical Center): In the early 1960s, some
commercial peritoneal dialysate utilized sorbitol as an osmotic
agent. Subsequently such dialysate was withdrawn from the
market because it caused hyperosmotic coma. Does this mean
that any poorly metabolized osmotic agent cannot be used in
peritoneal dialysis? I am curious about why shrinkage of the
brain causes coma.
DR. KLEEMAN: I would say that any dialysis fluid with a
poorly metabolized substance that is water-soluble—whether
it's ionized or not, and therefore, of low lipid solubility—would
cause an effective hyperosmolar state with regard to CNS.
Exactly how brain cell contraction or dehydration causes coma,
I do not know.
DR. JACOB GREEN (Nephrology Division, Cedars-Sinai Med-
ical Center): How do you reconcile the effectiveness of glucose
as a hyperosmotic agent with some prior observations that
hyperglycemia doesn't stimulate ADH secretion [75] and that in
fact it even suppresses ADH release [76]?
DR. KLEEMAN: It is known that the capillaries of the neuro-
hypophyseal system are not part of the blood-brain barrier.
There must be a much higher level of cell permeability in this
area to glucose as well as to urea. Urea, also a very good brain
dehydrating agent, does not cause the release of ADH.
DR. DAVID LEE (Chief, Nephrology Section, Sepulveda
Veterans Administration Medical Center): This patient sus-
tained two complications: one characterized by water move-
ment into the brain and the other by water movement out of the
brain, yet both complications led to systemic hypertension.
Would you comment?
DR. KLEEMAN: Obviously in both cases, the hypertension, or
its worsening, occurred because of something going on in the
brain. In the first case, dialysis disequilibrium, there's no
question that the brain swells and that cerebral spinal fluid
pressure increases. In fact, autopsy has revealed brain swelling.
We all know that when cerebral edema (brain swelling) is
present, one of the classic concomitants is a progressive rise in
blood pressure. This increase might be a protective mechanism
to keep cerebral blood flowing. But exactly how brain swelling
and increased volume of the brain in turn lead to the marked
increase in peripheral vasoconstriction, I do not know.
In the second case, I would say that the acute rise in blood
pressure did not result from the profound hyperosmolar state
but more likely was due to the acute rise in blood calcium in a
uremic patient with secondary hyperparathyroidism. We know
that hypercalcemia in this setting can significantly increase
blood pressure.
DR. JOHN T. HARRINGTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): One must be
impressed with the remarkable permeability and transport
characteristics of brain endothelia that you have described.
Have any studies been done on electrical resistance and per-
meability of brain endothelial cells taken from animals with any
of a variety of metabolic disturbances? I am particularly inter-
ested in studies with hypercalcemia because I don't understand
the mechanism of the coma due to hypercalcemia.
DR. KLEEMAN: I an unaware of any in-vivo or in-vitro studies
on brain capillary endothelial cells in the vast majority of the
disorders of water and electrolyte metabolism we encounter in
clinical medicine. In profound hyperosmolar states, and in the
severe hypercarbia of respiratory acidosis, the BBB clearly
loses its selective permeability characteristics. In the former, as
I mentioned earlier, hyperosmolar solute contact with the
endothelial cells leads to apparent separation or breakdown of
their tight junctions [56]. The mechanism by which hypercarbia
impairs the BBB is unknown. With respect to hypercalcemia, I
too am at a loss to explain the coma occasionally caused by
marked hypercalcemia. If the BBB and BCSFB are intact, the
1SF calcium ion concentrations should be normal; the cell
should not recognize or respond to the hypercalcemia. I have
been impressed by the occasional patient I have seen who has
severe hypercalcemia (>14 mg/dl) but who has no apparent
alteration of consciousness. Is it possible that the patient with
frank coma does not have an intact BBB and BCSFB or that an
associated abnormality is responsible? Only in the presence of
PTH excess, particularly when associated with azotemia, do we
see an increase in brain calcium content.
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DR. SHEIICH HAMAD (UCLA School of Medicine): What is
the mechanism of coma in metabolic alkalosis? Why do idio-
genic osmoles develop in hypernatremia and hyperglycemia and
not in mannitol-, glycerol-, or sucrose-induced hyperosmolar
states?
DR. KLEEMAN: With respect to your first question, metabolic
alkalosis with bicarbonate above 50 mEq/liter is often associ-
ated with confusion, lethargy, stupor, and seizures, but coma is
an uncommon event. The BBB and BCSFB remain intact in
severe metabolic alkalosis, and the pH of the CSF can change
less than 0.1 pH units at the same time that blood pH rises 0.2
to 0.3 pH units. But we should discuss the hyperbicarbonatemia
that accompanies chronic hypercapnea. As I mentioned, during
the hypercapnic state, the BBB may be defective. The brain
cells themselves and the choroid plexus epithelium can generate
increased amounts of bicarbonate as the dissolved CO2 in-
creases. If the hypercarbia is corrected too rapidly, patients
with chronic respiratory acidosis and its attendant hyperbicar-
bonatemia are susceptible to increasing confusion, asterixis,
seizures, stupor, and coma with ensuing death. The "unveiled"
acute severe metabolic alkalemia, as the pCO2 returns to
normal in blood and brain, leads to a profound decrease in
minutes in cerebral blood flow. At the same time, the CSF pH
can rise rapidly and, if the BBB is not normal, 1SF and cells can
experience this alkalosis.
In answer to your second question, I don't know why
idiogenic osmoles are not generated in mannitol-, glycerol-, and
sucrose-induced hyperosmolar states. Possibly it is because
these solutes are totally excluded from the brain cells, whereas
glucose and sodium are not. In turn these latter solutes might
"trigger" the metabolic pathways responsible for generating
the new osmoles.
DR. GEORGE HvosTnc (Fellow, Department of Medicine,
UCLA School of Medicine): Is the permeability of the brain
endothelial cell in diabetic patients different from that in non-
diabetics? What is the nature of the idiogenic osmoles that
develop with rapid hemodialysis, and how fast do they disap-
pear?
DR. KLEEMAN: I am not aware of any study in which the
transport and permeability characteristics of the endothelial cell
of the brain have been compared in the diabetic and nondiabetic
state. To respond to your second question, the idiogenic
osmoles associated with rapid hemodialysis can develop within
a few hours. I don't think that we ever studied the rate of
disappearance of these undetermined solutes. Remember that
in the chronic experimental uremic state, the total elevation in
osmolality in the brain is not just a consequence of the urea in
the brain increasing to the same level as in the blood. In the
chronic azotemic animal, over a number of days a significant
proportion of the total brain osmolality was due to idiogenic
osmoles. We did not determine the makeup of these idiogenic
osmoles.
DR. MICHAEL LEVINE (Nephrology Division, Cedars-Sinai
Medical Center): What is the explanation for coma occasionally
associated with severe hypophosphatemia?
Da. KLEEMAN: The literature contains a tremendous void
regarding a proper explanation for the CNS syndrome and the
metabolic derangements in the brain in profound hypophos-
phatemia (<1.0 mg/dl). The syndrome can include delirium,
confusion, focal neurologic signs, convulsions, stupor, and
coma. As I mentioned earlier, certain circumstances of phos-
phate depletion are most often associated with altered states of
consciousness. Usually the patient is entering a phase of rapid
anabolism and at the same time is receiving inadequate phos-
phorus to supply the need of this metabolic state. This lack can
cause an acute intracellular depletion of inorganic phosphorus
and of certain high-energy organic phosphates. This occurrence
in the red cell prevents the maintenance of red blood cell 2,3
diphosphoglycerate essential for the regulation of oxyhemoglo-
bin dissociation. Thus 2,3 diphosphoglycerate leads to exces-
sive oxygen binding to hemoglobin with inadequate release and
delivery of oxgyen to the brain. In truth, however, the patho-
physiology and exact metabolic derangements in the brain in
severe phosphate depletion have not been studied adequately.
DR. KOPPLE: What do you think causes the change in the
concentration of the amino acids in the cells of the brain that are
part of the osmolar adaptation to hyper- and hyponatremia? Is
the cause an alteration in net intracellular protein breakdown or
synthesis, or a change in amino acid transport?
DR. KLEEMAN: A definitive answer to this excellent question
is not available. However, Thurston and associates, in their
recent publication on this subject, have summarized the avail-
able data and have suggested that a change in the rate of influx
and/or efflux of amino acids across the cell membrane probably
is responsible for the adaptive changes in amino acid levels in
hypo- and hypernatremic states [77].
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